GSA CAPITAL PARTNERS LLP

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1362033 LONDON, X0

Position in ARWR

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$555,835

-$357,431 QoQ

Shares Held

8,865

-87.6% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	IOVA	Iovance Biotherapeutics, Inc.	655,318	$2,726,122
2	IMVT	Immunovant, Inc.	65,267	$2,514,737
3	GOSS	Gossamer Bio, Inc.	14,986,947	$2,472,846
4	AXSM	Axsome Therapeutics, Inc.	9,419	$2,305,488
5	CABA	Cabaletta Bio, Inc.	668,563	$2,079,230
6	MLTX	MoonLake Immunotherapeutics	106,695	$2,077,351
7	ATYR	aTYR PHARMA INC	3,454,863	$2,062,553
8	CORT	Corcept Therapeutics Inc	23,257	$2,022,196

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$555,835	8,865	-87.6%	Shares	Sole	2026-05-08
2025-03-31	$913,266	71,685	+514.4%	Shares	Sole	2025-05-08
2024-12-31	$219,339	11,667	+6.1%	Shares	Sole	2025-02-07
2024-03-31	$314,571	10,999	-29.9%	Shares	Sole	2024-05-03
2023-12-31	$480,052	15,688	-67.0%	Shares	Sole	2024-02-16
2023-09-30	$1,277,050	47,527	+28.2%	Shares	Sole	2023-11-15
2023-03-31	$941,654	37,073	+223.9%	Shares	Sole	2023-05-12
2022-09-30	$378,323	11,447	-62.1%	Shares	Sole	2022-11-14
2022-06-30	$1,064,785	30,241	+166.5%	Shares	Sole	2022-08-09
2022-03-31	$521,802	11,346	+51.1%	Shares	Sole	2022-05-11
2020-03-31	$216,091	7,511	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.